Mitochondrial DNA copy number associates with insulin sensitivity and aerobic capacity, and differs between sedentary, overweight middle-aged males with and without type 2 diabetes by Constantin-Teodosiu, Dumitru et al.
Mitochondrial DNA copy number associates with insulin sensitivity and aerobic capacity, 1 
and differs between sedentary, overweight middle-aged males with and without type 2 2 
diabetes  3 
 4 
Dumitru Constantin-Teodosiu1, Despina Constantin1, Maurice M. Pelsers2, Lex B. Verdijk2, Luc 5 
van Loon2, and Paul. L. Greenhaff1 6 
 7 
1MRC/ARUK Centre for Musculoskeletal Ageing Research, National Institute for Health 8 
Research Nottingham Biomedical Research Centre, School of Life Sciences, Nottingham 9 
University Medical School, Nottingham, NG7 2UH, United Kingdom, 2NUTRIM School for 10 
Nutrition and Translational Research in Metabolism, Department of Human Biology and 11 
Movement Sciences, Maastricht University Medical Centre, Maastricht, Netherlands. 12 
 13 
Short running title: insulin resistance and mitochondria 14 
 15 
Corresponding author: Dumitru Constantin-Teodosiu, PhD 16 
Email: tim.constantin@nottingham.ac.uk 17 
Tel no +44-115-8230111 18 
Abstract word counts:  19 
Main body text word counts 20 
Reference number:  21 
Table number: 3 22 
Figure number: 2 23 
  24 
2 
Abstract 25 
Background/objectives: Increased risk of type 2 diabetes mellitus (T2DM) is linked to 26 
impaired muscle mitochondrial function and reduced mitochondrial DNA copy number 27 
(mtDNAnum). However, studies have failed to control for habitual physical activity levels, which 28 
directly influences both mtDNA copy number and insulin sensitivity. We, therefore, examined 29 
whether physical conditioning status (maximal oxygen uptake, V̇O2max) was associated with 30 
skeletal muscle mitochondrial volume and mtDNAnum, and was predictive of T2DM in 31 
overweight, middle-aged men. 32 
Methods: Whole-body physiological (ISI-insulin sensitivity index, HOMA-IR, V̇O2max) and 33 
muscle biochemical/molecular (vastus lateralis; mtDNAnum, mitochondrial and glycolytic 34 
enzymes activity, lipid content and markers of lipid peroxidation) measurements were 35 
performed in 3 groups of overweight, middle-aged male volunteers (n=10 per group): sedentary 36 
T2DM (ST2DM); sedentary control (SC) and non-sedentary control (NSC), who differed in 37 
aerobic capacity (ST2DM<SC<NSC). 38 
Results: mtDNAnum was greater in NSC vs SC and ST2DM (P<0.001; P<0.001), and less in 39 
ST2DM vs SC (P<0.01). Across all groups, mtDNAnum positively correlated with ISI (P<0.001; 40 
r=0.688) and V̇O2max (normalised to free fat mass; r=0.684, P<0.001), and negatively correlated 41 
to HOMA-IR (r=-0.544, P<0.01). The activity of mitochondrial enzymes (GluDH, CS and -42 
HAD) was greater in NSC than ST2DM (P<0.01, P<0.001 and P<0.05) and SC (P<0.05, P<0.01 43 
and P<0.05), but similar between ST2DM and SC. Intramuscular free fatty acids, triglycerides 44 
and malondialdehyde contents were similar between ST2DM and SC.  45 
Conclusions: Body composition and indices of muscle mitochondrial volume/function were 46 
similar between SC and ST2DM. However, mtDNAnum differed and was positively associated 47 
with ISI, HOMA-IR and V̇O2max across all groups. Collectively, the findings support the 48 
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contention that habitual physical activity is a key component of T2DM development, possibly 49 
by influencing mtDNAnum.  50 
  51 
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Introduction 52 
Excess caloric intake and lack of physical activity are primary causes of increasing obesity 53 
prevalence worldwide. Being overweight or obese is commonly associated with elevated 54 
circulating free fatty acid concentrations and increased risk of metabolic inflexibility (defined 55 
as the inability of skeletal muscle to switch from fat to carbohydrate oxidation in response to 56 
increased circulating glucose and insulin concentrations), a central feature of insulin resistance 57 
(IR) and type 2 diabetes (T2DM). However, not all obese people develop T2DM, and not all 58 
T2DM patients are obese. Alternatively, increased risk of T2DM development has been linked 59 
to reduced muscle mitochondrial function (defects in intrinsic mitochondrial ATP production) 60 
and reduced mitochondrial DNA copy number (mtDNAnum) 1-5. However, these observations 61 
have not been consistent across studies, and some would argue that declines in mitochondrial 62 
function are normalised when differences in physical activity levels (V̇O2), mitochondrial 63 
content and insulin action are considered 6-8. It is also noteworthy that mitochondrial respiration 64 
(with or without normalisation for mitochondrial content) does not change following gastric-65 
bypass induced improvements in insulin sensitivity 9. Therefore, whether reduced intrinsic 66 
mitochondrial function is causative in the induction of insulin resistance/T2DM, or contributes 67 
to increased susceptibility to T2DM, or arises as a consequence of existing insulin resistance 68 
remains an openly debated topic.  69 
 70 
Mitochondria are the site of cellular oxidative phosphorylation processes in which fat, 71 
carbohydrates, and amino acids are oxidatively decarboxylated to produce reducing equivalents,  72 
which are subsequently used to generate ATP. Also, mitochondrial function is an integral part 73 
of glucose-stimulated insulin secretion in pancreatic beta-cells 10. The dynamic equilibrium 74 
between mtDNA synthesis and degradation determines the mtDNAnum, which is relatively stable 75 
under normal physiological conditions. However, changes in mtDNAnum are associated with 76 
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pathological changes in tissues and organs. Human mtDNA resides in hundreds to thousands of 77 
copies in each cell and encodes for 13 structural proteins, which are subunits of the oxidative 78 
phosphorylation electron transport chain, in addition to 2 ribosomal RNAs (rRNA) and 22 79 
transfer RNAs (tRNA). However, mtDNA replication, transcription, translation and repair is 80 
controlled by proteins encoded by nuclear DNA (nDNA) 11. Qualitative changes in the mtDNA 81 
sequence induced by the mitochondrial reactive oxygen species (ROS), such as mutations and 82 
deletions, have been implicated in the pathogenesis of T2DM 12. However, this can only account 83 
for a small proportion of patients with T2DM 13. 84 
Nevertheless, it was demonstrated that the content of mtDNA decreased in patients with T2DM 85 
14-17 and that reduced mtDNA levels precede the development of diabetes 14, although not 86 
consistently 7, 8. A confounding factor that may have contributed to these conflicting 87 
observations is age since an age-related decline in mtDNAnum was previously identified in 88 
isolated human islets 15, 16 and rodent skeletal muscle 18. Similarly, regular physical activity by 89 
amplifying the signal for mitochondrial biogenesis can increase mitochondrial content and 90 
function in young and older volunteers 19, and also increases insulin sensitivity (IS) 20, while 91 
deconditioning has the opposite effects 21. Overall, therefore, it would be useful if one could 92 
control for those factors known to contribute to variation in the mtDNA copy number, such as 93 
age and aerobic training status (maximal oxygen uptake), to provide more informative insight 94 
of the role of mtDNAnum in T2DM risk. 95 
 96 
The present study therefore aimed to identify whether indices of whole-body insulin sensitivity 97 
(ISI) and insulin resistance (IR) were associated with (1) maximal oxygen uptake, (2) indices of 98 
skeletal muscle intrinsic mitochondrial function, (3) measures of skeletal muscle mitochondrial 99 
volume or (4) skeletal muscle mtDNAnum in a cohort of middle-aged male volunteers clustered 100 
6 
into sedentary T2DM (ST2DM), sedentary control (SC), and non-sedentary control (NSC) sub-101 
cohorts. 102 
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Materials and Methods 103 
Study participants 104 
This study was part of a previous project from which skeletal muscle fatty acid transporter 105 
protein expression has been reported 22. A total of 10 male ST2DM patients, 10 normoglycaemic 106 
SC male volunteers, and 10 normoglycaemic NSC male volunteers provided informed consent 107 
to participate in this study, which was approved by the Maastricht University Medical Ethics 108 
Committee. All volunteers were overweight (BMI >25, Table 1). The ST2DM and SC 109 
volunteers were matched for age, BMI and whole-body fat mass (Table 1), and none was or had 110 
been engaged in a physical activity training programme. 111 
In contrast, the NSC volunteers reported cycling 3-4 times each week for more than 45 min. The 112 
inclusion of ST2DM patients was based entirely on their medical condition, and confirmation 113 
was verified with an oral glucose tolerance test (OGTT). Patient medication included 114 
Metformin, Amaryl, Lipitor, Glucophage, Avandia, Tolbutamide, Daonil and Statins. The 115 
average duration of clinical T2DM up to the start of the study was 7.5±1.1 yrs. Anthropometric, 116 
physiological and biochemical parameters for each group of volunteers are shown in Table 1. 117 
 118 
Study protocol  119 
Subjects reported to the laboratory after an overnight fast. Following 30 min of supine rest, a 120 
vastus lateralis muscle biopsy sample was obtained from each volunteer under local anaesthesia 121 
(lignocaine 2%) using a Bergstrom biopsy needle. The muscle biopsy specimens were snap-122 
frozen in liquid nitrogen and stored at -80°C until analyses were undertaken at a later date.  123 
Following a further 30 min of supine rest, a catheter (Baxter BV, Utrecht, the Netherlands) was 124 
inserted into an antecubital vein, and a blood sample was drawn (t = 0 min), after which 75 g of 125 
glucose (dissolved in 250 mL water) was ingested, and a further blood sample was collected at 126 
t = 120 min. Plasma glucose concentrations (Table 1) were measured (Yellow Spring glucose 127 
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analyser) to assess glucose intolerance and type 2 diabetes according to the American Diabetes 128 
Association guidelines (www.diabetes.org) while serum, which was stored for 2 yrs at -80ºC, 129 
was used to assess insulin concentration (ELISA kit; Mercodia, Uppsala, Sweden). A small 130 
blood specimen collected at 0 times was used to measure the glycosylated haemoglobin HbA1c 131 
using an A1CNow+ device (Medisave, UK). 132 
 133 
Maximal power output (Wmax) and maximal oxygen uptake (V̇O2max) were determined on an 134 
electronically braked cycle ergometer (Lode Excalibur, Groningen, the Netherlands) during an 135 
incremental exhaustive exercise test undertaken one week before muscle biopsy sampling 136 
(Table 1). Oxygen uptake (V̇O2) and carbon dioxide production (V̇CO2) were measured 137 
continuously (Oxycon; Mijnhart, Breda, the Netherlands). Body composition was assessed 138 
using the hydrostatic weighing method in the morning after an overnight fast. Simultaneously, 139 
residual lung volume was measured by the helium-dilution technique using a spirometer 140 
(Volugraph 2000; Mijnhart, Bunnik, the Netherlands). Body weight was measured with a digital 141 
balance. Body fat percentage was calculated using Siri’s equation 23. Fat-free mass (FFM) was 142 
calculated by subtracting fat mass (FM) from total body weight (Table 1). 143 
 144 
Insulin sensitivity index (ISI 0, 120): was calculated using serum insulin and plasma glucose 145 
concentrations in a fasted state (0 min) and 120 min post-oral glucose ingestion according to 146 
Gutt et al. 24. The ISI0,120 index (ml
2/kg/IU/min-1) was defined as:  147 
ISI0, 120 =
75,000+(G0−G120) x 0.19 x m
120 x Gmean x log (Imean)
 148 
where 75,000 represents the oral glucose load in mg, G0 represents fasting plasma glucose 149 
concentration (mg/dL), G120 - represents plasma glucose concentration at 120 min (mg/dL), 0.19 150 
represents glucose space in L/kg body weight, m represents body mass (kg), 120 represents 151 
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duration of the test (min), Imean represents mean serum insulin concentration during the test 152 
(mIU/L) and Gmean represents mean plasma glucose concentration during the test (mmol/L).  153 
 154 
HOMA-IR: The homeostatic model assessment (HOMA), which is a method used to quantify 155 
insulin resistance, was calculated as: 156 
Plasma glucose concentration (mmol/L) x serum insulin concentration (mIU/L) 157 
22.5 158 
Where 22.5 is a normalising factor representing the product of normal fasting plasma glucose 159 
concentration of 4.5 mmol/L and normal fasting plasma insulin concentration of 5 IU/mL.  160 
 161 
Muscle lipid peroxidation: Muscle malondialdehyde (MDA) content was determined as an 162 
indicator of lipid peroxidation products based on the method of Erdelmeier et al. 25. Briefly, 163 
frozen muscle tissue was homogenised in 5 mmol/L butylated hydroxytoluene in 20 mmol/L 164 
phosphate buffer pH 7.4, followed by centrifugation at 3,000 g at 4°C. Clear muscle lysate was 165 
acidic hydrolysed at 60°C for 80 min followed by mixing with N-methyl-2-phenylindol in 3:1 166 
(v/v) acetonitrile: methanol, incubation at 45°C for 60 min and finally centrifuged at 15,000 g 167 
for 10 min to clarify. Absorbance was measured spectrophotometrically at 586 nm. The 168 
concentration of malondialdehyde (μmol/L/mg protein) was calculated using 1,1,3,3-169 
tetramethoxypropane as a standard. 170 
 171 
Muscle free fatty acid and triglyceride content:  172 
Frozen muscle aliquots were homogenized in a Potter glass homogenizer for 3 min with 200 µl 173 
buffer (10 mmol/L Tris/HCl, pH 7.0 containing 154 mmol/L NaCl, 1 mmol/L EDTA, and 1% 174 
Triton X-100)/mg wet weight. The muscle lysates were then centrifuged at 24,000 g for 10 min. 175 
The pellets were discarded, and each supernatant was split into two aliquots. In the first aliquot, 176 
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levels of unbound free fatty acids (NEFA) only were measured using a WAKO NEFA assay kit, 177 
while in the second aliquot, through alkaline hydrolysis, the pools of free NEFA and NEFA 178 
released from triglycerides hydrolysis were determined. A 10 point standard curve generated 179 
from 1 mmol/L stock oleic acid solution was run in parallel. The triglycerides content was 180 
calculated by subtracting the free NEFA from the pooled NEFA values. 181 
 182 
Muscle enzymes activities: The activities of muscle mitochondrial glutamate dehydrogenase 183 
(GluDH), citrate synthase (CS), and β-hydroacyl-CoA dehydrogenase (HAD) and cytosolic 184 
Gly3P dehydrogenase (Gly3PDH) were measured as described previously 21. Briefly, following 185 
the lysis of frozen muscle pieces (~5 mg wet weight) in buffer containing K2HPO4 and Triton 186 
X-100 using a Potter Elvehjem homogenizer the enzyme activities were measured 187 
spectrophotometrically in the presence of suitable cofactors, activators, and buffers specific for 188 
each enzyme. 189 
 190 
Relative mtDNA copy number: The extraction of nuclear (nDNA) and mitochondrial DNA 191 
(mtDNA) from skeletal muscle was accomplished according to the manufacturer’s 192 
recommendations using Qiagen QIAamp® DNA Mini kit. Briefly, the procedure involved 193 
initial tissue lysis in a buffer containing proteinase K, incubation for 3 hrs at 56°C to digest the 194 
myofibril proteins followed by the spinning of the lysates on silica-membrane-based nucleic 195 
acid purification columns and elution of the mtDNA and nDNA with appropriate buffers. Before 196 
the addition of buffer AL (Qiagen), 4 µl of free DNase activity RNase A stock solution 7,000 197 
U/ml was added to each sample lysate. The quality and quantity of DNAs were assessed by 198 
measurements at 260, 280 and 230 nm. The expression level of selected markers of nDNA and 199 
mtDNA used to evaluate their abundance was accomplished by using TaqMan probe real-time 200 
PCR. The TaqMan probe design for the detection of nDNA levels was based on interrogation 201 
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of the intron sequence spanning between exons 3-4 of the genomic hydroxymethylbilane 202 
synthase (HMBS) gene. The probe design for detection of mtDNA levels was based on 203 
interrogation of a stable fragment of the mtDNA loop, namely the mitochondrially encoded 204 
NADH:ubiquinone oxidoreductase core subunit 1 (ND1). The 2-Ct formula, where  = CtND1-205 
CtHMBS, was used to express the relative number of mtDNA copies to nDNA. 206 
 207 
Statistical analysis 208 
Data in text, tables, and figures are expressed as mean±SEM, with n=10 in each experimental 209 
group. Between-group differences were determined using one-factor analysis of variance 210 
(ANOVA). A Scheffe´s post-hoc test was applied in the case of a significant F-ratio to locate 211 
between-group differences. Significance was set at the 0.05 level of confidence. The strength of 212 
the linear correlations between the investigated variables (r) was obtained using Pearson’s 213 
correlation. Correlations were deemed to be significant at 0.05 and 0.01 levels (2-tailed). The 214 
contribution of the variation in mitochondrial enzyme activity, mtDNA, FFM and V̇O2max/FFM 215 
to overall variation in ISI and HOMA-IR were determined using a linear regression model (IBM 216 
SPSS Statistics 24 package). Sample size calculation was calculated using G-Power software 217 
(version 3.1.9.2, Dusseldorf University, Germany) for ANOVA one-way fixed effects given α 218 
= 0.05, number of groups = 3, power = 0.8 and effect size = 0.6. 219 
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Results 221 
Participant anthropometric, physiological and biochemical characteristics 222 
The anthropometric, physiological and biochemical characteristics of the ST2DM, SC and NSC 223 
groups are shown in Table 1. Subjects did not differ in age and whole-body fat-free mass. All 224 
volunteers were overweight (BMI >25), and body mass index in ST2DM was significantly 225 
greater than in NSC. Whole-body fat (%) in NSC was significantly less than in ST2DM and SC 226 
and similar between ST2DM and SC groups.  227 
 228 
Fasting plasma glucose concentration in ST2DM was significantly greater than NSC and SC. 229 
Post-feeding (120 min) plasma glucose concentration in ST2DM was significantly greater than 230 
SC and NSC. Fasting serum insulin concentration in ST2DM was significantly greater than 231 
NSC. Post-feeding (120 min) serum insulin concentration was not different across groups, 232 
although it tended to be less in NSC than in SC and ST2DM. The insulin sensitivity index (ISI) 233 
in SC and NSC was significantly greater than in ST2DM, and HOMA-IR in SC and NSC was 234 
significantly less than in ST2DM. Percentage glycated haemoglobin (HbA1c) in ST2DM was 235 
significantly greater than in NSC and SC. Maximal oxygen uptake in ST2DM was no different 236 
from SC, but when normalised to free fat mass (ml/min/kg FFA), V̇O2max in SC was significantly 237 
greater than in ST2DM. Irrespective of the reference base, V̇O2max in NSC was significantly 238 
greater than in ST2DM and SC (Table 1). Maximal power output in NSC was significantly 239 
greater than SC and ST2DM. 240 
 241 
Muscle biopsy analyses 242 
The muscle content of free fatty acids, triglycerides, determined as indices of muscle lipid 243 
availability and the muscle content of malondialdehyde (MDA), determined as an index of lipid 244 
peroxidation are presented in Table 2. Due to a scarcity of muscle tissue in some of the subjects 245 
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in the NSC group, muscle metabolites could not be determined in all volunteers, and therefore, 246 
this group was omitted. Nevertheless, no difference was observed between ST2DM and SC for 247 
any parameter.  248 
The individual and the mean relative mtDNA copy number displayed in Fig. 1 illustrates that 249 
on average NSC had a significantly greater number of mtDNA copies than SC (P<0.001) and 250 
ST2DM (P<0.001; 1,461±52, 749±34, 454±58, respectively). The SC mtDNA copy number 251 
was also greater than ST2DM (P<0.01). 252 
The maximal activity of 3 mitochondrial enzymes (GluDH, CS and HAD) was determined as 253 
indices of mitochondrial volume and function (CS). The activity of all was greater in NSC 254 
compared with ST2DM and SC, but no differences were seen between ST2DM and SC (Fig. 255 
2A). The maximal activity of the Gly3PDH enzyme was used as a marker of capacity for 256 
glycolytic energy production. There was no significant difference between SC and ST2DM 257 
volunteers, but Gly3PDH activity was less in NSC compared with both groups (both P<0.001; 258 
Fig. 2B). 259 
Pearson correlations between the relative mtDNA copy number and ISI, HOMA-IR, V̇O2max 260 
normalised to FFM and mitochondrial enzyme activities across groups are presented in Table 3. 261 
Across all individuals, mtDNAnum highly associated with ISI, HOMA-IR, mitochondrial enzyme 262 
activities (GlutDH, and CS) and  V̇O2max/FFM.  263 
  264 
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Discussion 265 
The present study demonstrates that in a cohort of overweight, middle-aged male volunteers, 266 
mtDNAnum is ordered as NSC > SC > ST2DM. Furthermore, across all individuals, mtDNAnum 267 
was highly correlated with ISI, HOMA-IR, mitochondrial volume markers (GlutDH and CS 268 
activities) and V̇O2max normalised to FFM, while the associations between indices of 269 
mitochondrial volume and ISI and HOMA-IR were less robust. These observations, together 270 
with the knowledge that there was no difference in body composition or muscle lipids between 271 
SC and ST2DM volunteers, leads to the conclusion that mtDNAnum is a sensitive index of insulin 272 
sensitivity, which most likely reflects mitochondrial mass and supports the notion that regular 273 
exercise exerts a protective role against the development of IR and T2DM.  274 
 275 
In the present study, a significant difference in mtDNAnum was observed between SC and 276 
ST2DM groups, despite no between-group differences in muscle CS activity. Frequently, CS 277 
activity shows concordance with proteins entirely coded by mtDNA, such as complex I, II and 278 
IV activity in both young and older subjects 26, 27, and it is often used as an index of muscle 279 
‘mitochondrial content/volume’. However, it has to be recognised that CS protein is coded by 280 
nDNA, rather than by mtDNA, indicating that the discordance between CS activity and mtDNA 281 
in the present study may not be entirely unexpected. In line with the CS findings, other 282 
mitochondrial enzyme activity measurements (GlutDH and HAD), body composition 283 
measurements (% whole body fat and FFM), muscle levels of free fatty acids, triglycerides and 284 
malondialdehyde (a marker of lipid peroxidation; all of which have been reported to be causative 285 
of muscle insulin resistance), were similar in the SC and ST2DM groups. However, the V̇O2max 286 
normalised to FFM in SC was significantly greater than in the T2DM group, presumably 287 
reflecting greater habitual physical activity levels in SC compared with ST2DM. In line with 288 
this contention, Table 3 illustrates that mtDNAnum was found to associate strongly with indices 289 
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of insulin sensitivity (ISI and HOMA-IR) and V̇O2max normalised to FFM across all volunteers, 290 
and far better than the other muscle level measurements made. 291 
It is worth commenting that the whole-body ISI did not associate with V̇O2max across all study 292 
volunteers. This finding may be accounted for by the presence of additional factors that 293 
contribute to the biological variation of ISI and V̇O2max. Indeed, our linear regression model 294 
showed that 68% of the variation of ISI was accounted for by the variation of the mtDNA, 295 
GlutDH and FFM (all muscle related), while the variation of V̇O2max was more most likely to 296 
be accounted for by adaptations of the cardiovascular and pulmonary systems in addition to 297 
those adaptations occurring at the muscle level.  298 
 299 
Declines in mtDNAnum and mitochondrial function have been linked to human ageing 28 and 300 
thereby age-related reductions in physical function 29. This age-related decline in mtDNAnum 301 
does not appear to be gender-related as mtDNAnum in women and men was found to be almost 302 
the same 30. In contrast, mtDNAnum appears to be preserved in heart muscle with ageing, 303 
presumably due to its continuous contraction state 18. In keeping with these observations, human 304 
mtDNAnum also appears to be tissue-specific. Thus, values are reported to be greatest in muscle 305 
tissue, followed by blood vessels, and lowest in leucocytes (in both T2DM and control subjects) 306 
31. Although oxidative stress stimulates mitochondrial biogenesis, it also induces a greater 307 
degree of apoptosis in T2DM, resulting in a decrease in muscle tissue mtDNAnum 32. 308 
 309 
In conclusion, we report here the existence of a significant difference in ISI, HOMA-IR and 310 
mtDNAnum across SC and T2DM volunteers, despite indices in mitochondrial volume and 311 
function, and body composition and muscle free fatty acids, triglycerides and malondialdehyde 312 
being similar between sedentary and T2DM volunteers. Moreover, we found that mtDNAnum 313 
strongly correlates with indices of insulin sensitivity and V̇O2max, which most likely reflect 314 
16 
mitochondrial mass and supports the evidence that non-sedentary behaviour in the form of 315 
regular exercise exerts a protective role against the development of IR and T2DM.  316 
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Table 1. Anthropometric, physiological and biochemical characteristics of participants 428 
 429 
 
 
Type 2 
diabetes 
n = 10 
Sedentary 
control 
n = 10 
Non-sedentary 
control 
n = 10 
Age (yrs)  58.9±1.7 60.0±2.1 57.4±0.9 
BMI (kg/m2) 28.9±1.2 27.5±0.5 25.5±0.7* 
Whole-body fat (%) 28.8±1.8 29.2±1.3 17.2±1.2*# 
Whole-body FFM (kg) 64.0±1.9 61.3±1.5 63.6±1.0 
Fasting plasma glucose (mmol/L) 9.0±0.4 5.5±0.2* 5.7±0.1* 
Plasma glucose 120 min
 (mmol/L) 16.8±1.0 5.3±0.49* 5.3±0.4* 
Fasting serum insulin 0 min (mIU/L) 8.8±0.9 7.9±1.6 5.1±0.6
* 
Serum insulin 120 min (mIU/L) 45.2±7.8 48.4±8.0 29.4±6.3 
Insulin sensitivity index (ISI)a 46.8±1.8 83.6±5.8* 103.0±8.6** 
HOMA-IR 3.63±0.35 1.82±0.37*** 1.30±0.15*** 
HbA1c (%) 7.30±0.3 5.83±0.2* 5.78±0.1* 
V̇O2max (L/min) 2.90±0.20 3.19±0.19 3.80±0.12**# 
V̇O2max (mL/min/kg FFM) 45.0±2.3 52.0±2.7* 59.8±1.6***# 
Wmax 205±16 206±18 300±9**## 
BMI - body mass index, FFM - free fat mass, aml2/kg/IU/min. *, **, ***Significantly 430 
different from Type 2 diabetes group (P<0.05, P<0.01 and P<0.001, respectively). 431 
#Significantly different from the sedentary control group (P<0.05). 432 
  433 
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Table 2. Muscle content of lipids and their oxidation product (malondialdehyde) in sedentary 434 
control volunteers (n=10) and sedentary T2DM patients (n=10). 435 
 436 
Muscle metabolites Sedentary control Sedentary T2DM patients 
Malondialdehyde* 30.1±4.2 32.4±5.4 
Intramuscular free fatty acids# 11.66±0.68 15.21±2.92 
Intramuscular triglycerides# 1.10±0.04 0.85±0.13 
* mol/mg protein, #mmol/kg dry matter437 
24 
Table 3. Pearson correlations between muscle mtDNAnum, whole body insulin sensitivity index (ISI) and insulin resistance (HOMA-IR), and several 
muscle mitochondrial capacity indices (glutamate dehydrogenase - GlutDH, citrate synthase - CS, and β-hydroxy acyl-CoA dehydrogenase activity 
- HAD) and V̇O2max normalised to free fat mass (FFM), in three groups of late middle-aged males clustered according to aerobic capacity and the 
presence of T2DM. 
    mtDNA ISI 
HOMA-
IR GlutDH CS HAD 
 
V̇O2max/FFM 
mtDNA Pearson correlation - 0.688 -0.542 0.603 0.604 0.382 0.684 
 Sig (2-tailed) - 0.001 0.002 0.001 0.001 0.037 0.001 
ISI Pearson correlation 0.688 - -0.662 0.488 0.328 0.187 0.178 
 Sig (2-tailed) 0.001 - -0.001 0.006 0.077 0.321 0.348 
HOMA-IR Pearson correlation -0.542 -0.662 - -0.424 -0.325 -0.112 -0.229 
 Sig (2-tailed) 0.002 0.001 - 0.020 0.080 0.554 0.224 
GlutDH Pearson correlation 0.603 0.488 -0.424 - 0.715 0.605 0.217 
 Sig (2-tailed) 0.001 0.006 0.020 - 0.001 0.001 0.249 
CS Pearson correlation 0.604 0.328 -0.325 0.715 - 0.654 0.161 
 Sig (2-tailed) 0.001 0.077 0.080 0.001 - 0.001 0.394 
HAD Pearson correlation 0.382 0.187 -0.112 0.605 0.654 - 0.350 
 Sig (2-tailed) 0.037 0.321 0.554 0.001 0.001 - 0.105 
V̇O2max/FFM Pearson correlation 0.684 0.278 -0.229 0.217 0.161 0.350 - 
 Sig (2-tailed) 0.001 0.240 0.224 0.249 0.394 0.105 - 
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Figure Legends  
 
Figure 1 Relative mtDNA copy number in vastus lateralis muscle of sedentary Type 2 diabetes 
mellitus (ST2DM), sedentary control (SC) and non-sedentary control (NSC) volunteers. Data 
represent mean+SEM and individual values. Significant difference between groups depicted as: 
** (P<0.01); *** (P<0.001).  
 
Figure 2. Mitochondrial volume markers (glutamate dehydrogenase, citrate synthase and β-
hydroxyacyl-CoA dehydrogenase activity; Fig. 2A) and glycolytic capacity index 
(glyceraldehyde-3P-dehydrogenase; Fig. 2B) in vastus lateralis muscle of sedentary Type 2 
diabetes mellitus (ST2DM), sedentary control (SC) and non-sedentary control (NSC) 
volunteers. Data represent mean+SEM and individual values. *, **, ***Significantly different from 
ST2DM; P<0.05, P<0.01, and P<0.010, respectively. †, ††, †††Significantly different from SC; 
P<0.05, P<0.01, P<0.001, respectively. 
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